An experimental medication that targets a protein in Ebola virus called VP24 protected 75% of a group of monkeys that were studied from Ebola virus infection, according to new research conducted by the U.S. Army, in collaboration ...
Feb 10, 2015
0
8
Scientists have developed a novel treatment approach for persistent viral infections such as herpes.
Dec 3, 2014
0
1
The skin condition neurodermatitis affects nearly one in four children and also occurs frequently in adults. Many patients also develop infections in the dry, open patches of skin, for example due to colonization by the pathogenic ...
Nov 19, 2014
0
0
Some MRSA bugs in UK hospitals can be traced back to a type of bacteria found in farm animals, a study suggests.
Nov 3, 2014
0
0
In the ongoing struggle to prevent and manage seasonal flu outbreaks, animal models of influenza infection are essential to gaining better understanding of innate immune response and screening for new drugs. A research team ...
Oct 1, 2014
0
0
Millions of people throughout the world are infected with hepatitis C virus (HCV). Left untreated, infection results in serious complications such as cirrhosis of the liver and cancer. Many HCV-infected patients respond well ...
Jul 8, 2014
0
0
Antibodies and their derivatives can protect plants and animals—including humans—against viruses. Members of this class of drugs are usually highly specific against components of a particular virus, and mutations in the ...
Jun 26, 2014
0
0
A shared population of methicillin-resistant Staphylococcus aureus (MRSA) bacteria circulates both in humans and companion animals, according to a study published this week in mBio, the online open-access journal of the American ...
May 13, 2014
0
0
More than 90 percent of all adults are carriers of the oncogenic Epstein-Barr Virus (EBV). Primary infection with this herpes virus as a young child is generally not linked to any symptoms, and usually offers life-long protection ...
Dec 19, 2013
0
0
An international team of scientists, with the participation of the Universitat Autònoma de Barcelona, have developed a compound to treat leishmaniasis in humans using today's most commonly prescribed drug, but with an 83 ...
Nov 5, 2013
0
0
